Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria?

Chanaz Salmi1, Celine Loncle, Nicolas Vidal

  • 1UMR-MD1, Facultés de Médecine et de Pharmacie, Marseille, France.

Plos One
|July 24, 2008
PubMed

Insights

Squalamine disrupts bacterial membrane integrity, showing effectiveness against multidrug-resistant (MDR) pathogens. Its unique action offers a promising alternative to overcome antibiotic resistance.

Area of Science:

  • Biochemistry
  • Microbiology
  • Pharmacology

Background:

  • Antibiotic resistance is a growing global health threat.
  • Multidrug-resistant (MDR) pathogens pose significant challenges to existing treatments.
  • Novel therapeutic strategies are urgently needed to combat resistant bacterial infections.

Purpose of the Study:

  • To investigate the antibacterial activity of squalamine.
  • To explore squalamine's mechanism of action against bacterial membranes.
  • To evaluate squalamine's potential as an alternative treatment for MDR pathogens.

Main Methods:

  • Assessing squalamine's effect on membrane integrity via ATP release and dye entry assays.
  • Testing squalamine's activity against bacterial pathogens with multidrug-resistance phenotypes.
  • Evaluating squalamine's efficacy in comparison to antibiotics like polymyxin B.

Main Results:

  • Squalamine demonstrates membrane-active properties, compromising bacterial membrane integrity.
  • The molecule retains activity against bacterial strains resistant to conventional antibiotics, including polymyxin B.
  • Squalamine's structure and mechanism suggest insensitivity to common efflux resistance.

Conclusions:

  • Squalamine represents a potential therapeutic agent against MDR bacterial pathogens.
  • Its unique mechanism of action may bypass existing resistance pathways.
  • Squalamine offers a promising alternative to address the limitations of current antibacterial therapies.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...